Literature DB >> 3553849

Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man.

J H Henriksen, B Tronier, J B Bülow.   

Abstract

Plasma concentrations of insulin, C-peptide, and proinsulin were measured in different vascular beds in order to determine renal, hepatic, and systemic kinetics of the endogenous peptides in the fasting condition. Nineteen nondiabetic subjects were studied, two were normal, nine had minor vascular disorders, four had cirrhosis without organic kidney disease, and four had organic kidney disease with moderately decreased glomerular filtration rate. In subjects without organic kidney disease the arteriorenal venous extraction ratios of insulin, C-peptide, and proinsulin were mean 0.27, 0.20, and 0.21, respectively (n = 14). These values were significantly reduced in kidneys with organic disease. Renal plasma clearance values of insulin, C-peptide, and proinsulin were mean 113, 87, and 90 mL/min, respectively (n = 6). Urinary clearances were substantially lower (0.8, 13, 3.5 mL/min, respectively), indicating that a significant degradation of these peptides also takes place in the normal kidney. In subjects without liver disease the estimated hepatic extraction ratio of insulin was mean 0.48, under the assumption that no C-peptide is removed by the liver. Endogenously released insulin was removed from plasma in kidney, liver, and elsewhere in the approximate proportion 10%:65%:25%, whereas, C-peptide was removed by one half in kidney and the other half elsewhere. The overall metabolic clearance rates of insulin and C-peptide were estimated to be 15 and 4.5 mL/min/kg, respectively. The results indicate that the kidney contributes substantially to removal of insulin, C-peptide, an proinsulin, mainly by degradation, less by urinary excretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553849     DOI: 10.1016/0026-0495(87)90044-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  27 in total

1.  Insulin clearance is different in men and women.

Authors:  Michael D Jensen; Soren Nielsen; Nidhi Gupta; Rita Basu; Robert A Rizza
Journal:  Metabolism       Date:  2011-10-13       Impact factor: 8.694

2.  Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.

Authors:  M Wallensteen; G Dahlquist; B Persson; M Landin-Olsson; A Lernmark; G Sundkvist; B Thalme
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

3.  A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant.

Authors:  M Giordano; V Colella; A Dammacco; C Torelli; G Grandaliano; A Teutonico; T Depalo; D A Caringella; S Di Paolo
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

4.  Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.

Authors:  M A Nauck; M Büsing; C Orskov; E G Siegel; J Talartschik; A Baartz; T Baartz; U T Hopt; H D Becker; W Creutzfeldt
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

5.  Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study.

Authors:  Bente Bryhni; Egil Arnesen; Trond G Jenssen
Journal:  BMC Endocr Disord       Date:  2010-12-16       Impact factor: 2.763

6.  Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C-peptide profiles in the basal state and after oral glucose.

Authors:  M Nauck; M Büsing; E G Siegel; J Talartschik; A Baartz; T Baartz; U T Hopt; H D Becker; W Creutzfeldt
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

7.  Hyperinsulinemia after pancreatic transplantation. Prediction by a novel computer model and in vivo verification.

Authors:  R C Earnhardt; D D Kindler; A M Weaver; G Cornett; D Elahi; J D Veldhuis; J B Hanks
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

8.  Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Sjöberg; B L Johansson; J Ostman; J Wahren
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

9.  A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation.

Authors:  Olivia I Okereke; Dennis J Selkoe; Michael N Pollak; Meir J Stampfer; Frank B Hu; Susan E Hankinson; Francine Grodstein
Journal:  Int J Geriatr Psychiatry       Date:  2009-02       Impact factor: 3.485

10.  Short-term effects of recombinant human growth hormone and feeding on gluconeogenesis in humans.

Authors:  Walid Kaplan; Agneta L Sunehag; Harry Dao; Morey W Haymond
Journal:  Metabolism       Date:  2008-06       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.